Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center

Fig. 2

A Pruritus numeric rating scale before and after MARS® therapy in the refractory pruritus group. Numeric rating scale ranges from 0 (no itch) to 10 (worst imaginable itch). Patients perception of pruritus was decreased from 9 [8–10] to 2 [0–3] (p < 0.01) after MARS® therapy. Results are shown as median, first quartile, third quartile, minimum and maximum. B Richmond Agitation Sedation Scale (RASS) variation before and after MARS.® therapy in the drug intoxication group. RASS score improved in 11 out of 12 admissions (p < 0.01)

Back to article page